J. Jansen

发表

Dose-response relations between occupational exposures to physical and psychosocial factors and the risk of low back pain

H. Morgenstern, A. Burdorf, J. Jansen, 2004, Occupational and Environmental Medicine.

Effects of measurement strategy and statistical analysis on dose-response relations between physical workload and low back pain

A. Burdorf, J. Jansen, Jeroen P. Jansen, 2003, Occupational and environmental medicine.

Self-monitoring of glucose in type 2 diabetes mellitus:a Bayesian meta-analysis of direct and indirect comparisons

J. Jansen, 2006, Current Medical Research and Opinion.

Network meta-analysis of survival data with fractional polynomials

J. Jansen, 2011, BMC medical research methodology.

A Description of the IVI-RA Model v 2 . 0 ∗ †

J. Jansen, D. Incerti, 2019 .

Introduction to Decision-Theoretic Networks for Pharmacoeconomics

G. Baio, J. Jansen, 2005 .

Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.

Joseph C Cappelleri, Georgia Salanti, Jeroen P Jansen, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis

J. Jansen, H. Thom, J. Shafrin, 2020, BMJ Open.

A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer

J. Jansen, P. Schmid, S. Saletan, 2014, BMC Medicine.

Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models.

J. Jansen, P. Schmid, M. Ouwens, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck

J. Jansen, M. Posner, A. Parthan, 2009, Head & neck.

Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK

J. Jansen, P. Bacon, E. Choy, 2007, Current medical research and opinion.

Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.

J. Jansen, G. Capkun-Niggli, M. Ouwens, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis

J. Jansen, Jie Zhang, S. Cope, 2012, BMC Pulmonary Medicine.

Critical Appraisal Of Network Meta-Analyses Evaluating The Efficacy And Safety Of New Oral Anticoagulants In Atrial Fibrillation Stroke Prevention Trials.

J. Jansen, A. Clemens, H. Noack, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Aligning text mining and machine learning algorithms with best practices for study selection in systematic literature reviews

J. Jansen, S. Kanters, E. Popoff, 2020, Systematic Reviews.

The economic burden of kidney graft failure in the United States

B. Kasiske, J. Jansen, J. Sussell, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands

S. Sen, J. Jansen, S. Gaugris, 2008, Current medical research and opinion.

Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.

P. Lorigan, J. Jansen, M. Ouwens, 2012, The oncologist.

PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1

M. Kraemer, J. Jansen, G. Capkun-Niggli, 2012 .

An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin

L. Billings, J. Jansen, A. Andersen, 2018, Journal of medical economics.

Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.

F. Aversa, J. Jansen, Ritesh N. Kumar, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Response to Letter to Editor Regarding "Comparing Efficacy, Safety, and Pre-Infusion Period of Axicabtagene Ciloleucel vs Tisagenlecleucel in Relapsed/Refractory Large B-Cell Lymphoma".

J. Jansen, F. Locke, O. Oluwole, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Letter to the Editor Regarding "Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma".

J. Jansen, F. Locke, O. Oluwole, 2020 .

A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly

M. Van Ranst, J. Jansen, Litjen Tan, 2015, Infectious Diseases and Therapy.

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands

J. Jansen, J. Janssen, L. Span, 2010, Annals of Hematology.

Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands

J. Jansen, B. Rijnders, L. Span, 2008, European journal of haematology.

Economic outcomes of treatment for ureteral and renal stones: a systematic literature review.

J. Lingeman, B. Matlaga, J. Jansen, 2012, The Journal of urology.

Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer.

D. Camidge, J. Jansen, J. Penrod, 2020, Journal of comparative effectiveness research.

A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes.

J. Jansen, A. Davies, I. Eijgelshoven, 2014, Journal of pain and symptom management.

Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany.

J. Jansen, A. Resch, W. Kern, 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.

J. Jansen, A. Clemens, H. Noack, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Heterogeneity and Subgroup Analysis in Network Meta-Analysis

J. Jansen, 2020 .

The number needed to treat and relevant between-trial comparisons of competing interventions

J. Jansen, J. Khalid, H. Patel, 2018, ClinicoEconomics and outcomes research : CEOR.

Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1

J. Jansen, R. Arjunji, O. Dabbous, 2019, Advances in Therapy.

Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma

J. Jansen, F. Davies, D. Ayers, 2021, Leukemia & lymphoma.

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer

J. Jansen, D. Vissers, T. Nolte, 2010, Current medical research and opinion.

Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia

J. Jansen, K. Batt, D. Ayers, 2019, BMC Medical Research Methodology.

Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis

J. Cappelleri, J. Jansen, J. Bradley, 2016, BMC Musculoskeletal Disorders.

Evidence Synthesis Methods to Estimate Subgroup Effects for Distributional Cost-effectiveness Analysis of New Treatments

J. Jansen, 2021 .

Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.

David C Hoaglin, Joseph C Cappelleri, Neil Hawkins, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Conducting Indirect Treatment Comparison and Network Meta-analysis Studies : Report of the ISPOR Task Force on Indirect Treatment Comparisons — Part 2

D. Hoaglin, J. Cappelleri, J. Jansen, 2010 .

Integrating elicited patient preferences and clinical trial data in a quantitative model for benefit-risk assessment

A. Hauber, M. IJzerman, J. Jansen, 2012 .

hesim: Health Economic Simulation Modeling and Decision Analysis

J. Jansen, D. Incerti, 2021, 2102.09437.

R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment.

Gianluca Baio, Devin Incerti, Howard Thom, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis

Devin Incerti, Jeroen P. Jansen, Darius N. Lakdawalla, 2019, PharmacoEconomics.

Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing

Kristian Thorlund, Robin Christensen, Jeroen P Jansen, 2015, Current medical research and opinion.

Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis.

J. Reginster, J. Cappelleri, J. Jansen, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women

J. Reginster, J. Jansen, S. Sutradhar, 2014, Current medical research and opinion.

Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized, controlled trials.

J. Lingeman, B. Matlaga, J. Jansen, 2012, The Journal of urology.

Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.

Joseph C Cappelleri, Rachael Fleurence, Neil Hawkins, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers

Huseyin Naci, Jeroen P Jansen, H. Naci, 2013, BMC Medicine.

Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis

Jeroen P. Jansen, Maarten J. IJzerman, Henk Broekhuizen, 2015, BMC Medical Informatics and Decision Making.

Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis

A. Hamed, J. Jansen, B. Schoser, 2016, Journal of Neurology.

Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis

M. Kraemer, J. Jansen, P. Jones, 2013, Respiratory Research.

Comparative Effectiveness of Efavirenz, Protease Inhibitors, and Raltegravir-Based Regimens as First-Line Treatment for HIV-Infected Adults: A Mixed Treatment Comparison

J. Jansen, Ritesh N. Kumar, M. Vieira, 2011, HIV clinical trials.

Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons.

Jeroen P Jansen, Bruce Crawford, J. Jansen, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK

V. Gant, K. Bruynesteyn, J. Jansen, 2007, European journal of haematology.

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

J. Jansen, Ritesh N. Kumar, J. Lundberg, 2011, Scandinavian journal of infectious diseases.

Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis

A. Hamed, P. DasMahapatra, A. Ortiz, 2020, Clinical kidney journal.

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

J. Jansen, E. Choy, A. Ostor, 2012, PharmacoEconomics.

Epidemiology of HIV-related neuropathy: a systematic literature review.

J. Jansen, Sabyasachi Ghosh, A. Chandran, 2012, AIDS research and human retroviruses.

Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context

J. Jansen, M. Danese, P. Toth, 2017, Journal of medical economics.

Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy

J. Jansen, M. Lorenzi, B. Ambegaonkar, 2018, Clinical Research in Cardiology.

Multivariate Network Meta-Analysis of Survival Function Parameters

J. Jansen, Keith Chan, S. Cope, 2017 .

Multivariate network meta‐analysis of survival function parameters

Shannon Cope, Jeroen P Jansen, Keith Chan, 2020, Research synthesis methods.

Multi-state network meta-analysis of cause-specific survival data

Devin Incerti, Jeroen P. Jansen, Thomas Trikalinos, 2020, medRxiv.

The critical role of observational evidence in comparative effectiveness research.

Huseyin Naci, Jeroen P Jansen, Rachael L Fleurence, 2010, Health affairs.

Incorporating single‐arm evidence into a network meta‐analysis using aggregate level matching: Assessing the impact

Joy Leahy, Aisling O'Leary, Cathal Walsh, 2019, Statistics in medicine.

Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.

T. Huizinga, J. Jansen, A. Finckh, 2015, Journal of managed care & specialty pharmacy.

Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.

M. Hochberg, M. Boers, N. Wintfeld, 2010, Seminars in arthritis and rheumatism.

Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma.

R. Fonseca, J. Jansen, O. Landgren, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis.

Kristian Thorlund, Jason W Busse, Reed A Siemieniuk, 2014, JAMA.

Network Meta-Analysis for Decision-Making

Nicky J Welton, Alex J. Sutton, Jeroen P. Jansen, 2018 .

Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis

J. Jansen, S. Ogale, F. Buckley, 2014, Health and Quality of Life Outcomes.

Comparing Efficacy, Safety, and Pre-Infusion Period of Axicabtagene Ciloleucel vs Tisagenlecleucel in Relapsed/Refractory Large B-Cell Lymphoma.

J. Jansen, F. Locke, O. Oluwole, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancer.

J. Jakobsson, J. Jansen, K. Tolley, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

3 Cost Per Clinical Outcomes With Biologics for the Treatment of Moderately to Severely Active Ulcerative Colitis

J. Jansen, I. Ursan, M. Lorenzi, 2015 .

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – a network meta-analysis

J. Jansen, G. Capkun-Niggli, R. Gale, 2011, International journal of chronic obstructive pulmonary disease.

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis

M. Kraemer, J. Jansen, G. Capkun-Niggli, 2012, International journal of chronic obstructive pulmonary disease.

Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes

Shannon Cope, Jeroen P Jansen, J. Jansen, 2012, BMC Medical Research Methodology.

Predicting the long term course of low back pain and its consequences for sickness absence and associated work disability

A Burdorf, J P Jansen, A. Burdorf, 2006, Occupational and Environmental Medicine.

associated work disability and its consequences for sickness absence and Predicting the long term course of low back pain

A. Burdorf, J. Jansen, 2006 .

An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?

J. Jansen, J. Penrod, J. Shafrin, 2018, Health policy.

The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.

J. Jansen, M. Olson, G. Bergman, 2011, Seminars in arthritis and rheumatism.

Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies

J. Jansen, M. Olson, G. Bergman, 2009, Current medical research and opinion.

Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators

V. Strand, J. Jansen, D. Incerti, 2017, Journal of medical economics.

Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway

J. Jansen, S. Taylor, 2011, International journal of rheumatology.

Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project

Devin Incerti, Jeroen P. Jansen, Mark T. Linthicum, 2019, PharmacoEconomics.

Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons.

Georgia Salanti, Christopher H Schmid, Jeroen P Jansen, 2012, Journal of clinical epidemiology.

Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making

Shannon Cope, Jeroen P Jansen, J. Jansen, 2013, BMC Medical Research Methodology.

Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.

J. Jansen, B. Smiechowski, D. Spurden, 2016, Clinical therapeutics.

Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis

A. Hamed, J. Jansen, S. Kanters, 2019, Journal of Neurology.

A novel approach for evaluating level, frequency and duration of lumbar posture simultaneously during work.

A Burdorf, J P Jansen, A. Burdorf, 2001, Scandinavian journal of work, environment & health.

Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands

J. Jansen, N. Blijlevens, J. V. van't Wout, 2005, Current medical research and opinion.

PIN17 COST-EFFECTIVENESS OF MASS VACCINATION FOR VARICELLA IN FRANCE WITH MMRV VERSUS MMR

M. Postma, J. Jansen, M. Ouwens, 2008 .

Economic Evaluation of Posaconazole Versus Standard Azole Prophylaxis in High Risk Neutropenic Patients in The Netherlands.

J. Jansen, J. Janssen, B. Rijnders, 2007 .

Incorporating alternative design clinical trials in network meta-analyses

K. Thorlund, E. Mills, J. Jansen, 2014, Clinical epidemiology.

Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis

K. Thorlund, J. Jansen, E. Druyts, 2015, Journal of medical economics.

Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer.

E. Mills, J. Jansen, S. Kanters, 2015, JAMA.

PRS8 DISEASE PROGRESSION IN CYSTIC FIBROSIS — SYNTHESIS OF SURVIVAL EVIDENCE

J. Jansen, T. Liou, B. Harrow, 2011 .

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes

J. Jansen, M. Lorenzi, Å. Ericsson, 2018, PloS one.

Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework.

L. Garrison, J. Jansen, N. Devlin, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.

H. Tiddens, J. Jansen, G. Capkun-Niggli, 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression: An Application To Combination Therapies In Hiv.

K. Thorlund, E. Mills, J. Jansen, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

physical workload and low back pain analysis on dose-response relations between Effects of measurement strategy and statistical

A. Burdorf, J. Jansen, 2006 .

Indirect comparison of nivolumab ± ipilimumab (CheckMate 032) versus other treatments for recurrent small-cell lung cancer.

J. Jansen, J. Penrod, D. Ayers, 2019, Journal of comparative effectiveness research.

Relevance of American Society of Clinical Oncology Value Framework Will Be Improved if It Is Based on Network Meta-Analyses.

J. Jansen, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The relations between psychosocial factors at work and health status among workers in home care organizations

H. Eriksen, C. Ihlebæk, A. Burdorf, 2006, International journal of behavioral medicine.

Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis

A. Hamed, J. Jansen, B. Schoser, 2016, Journal of Neurology.

The critical role of observational evidence in comparative effectiveness research.

H. Naci, R. Fleurence, J. Jansen, 2010, Health affairs.

Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK

Jeroen P. Jansen, Yehuda Carmeli, Y. Carmeli, 2012, PharmacoEconomics.

Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis

J. Jansen, M. Lorenzi, M. Zoratti, 2016, Diabetes Therapy.

Comparative Effectiveness Research/Health Technology Assessment Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison

J. Jansen, G. Capkun-Niggli, R. Gale, 2012 .

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis

J. Jansen, D. Collier, D. Incerti, 2020, Journal of managed care & specialty pharmacy.

ABCL-289: Matching-Adjusted Indirect Comparison (MAIC) of Axicabtagene Ciloleucel (Axi-Cel) and Lisocabtagene Maraleucel (Liso-Cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) After Two or More Prior Lines of Therapy

J. Jansen, Z. Bashir, F. Locke, 2021 .

Comparative Effectiveness of Efavirenz, Protease Inhibitors, and Raltegravir-Based Regimens as First-Line Treatment for HIV-Infected Adults: A Mixed Treatment Comparison

J. Jansen, Ritesh N. Kumar, M. Vieira, 2011, HIV clinical trials.